Status
Conditions
Treatments
About
The aim of this multicenter, randomized, controlled, open-label trial is to investigate the efficacy of early treatment with HFNO compared with SOT in preventing early deterioration of patients admitted to the ER because of acute hypoxemic respiratory failure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Respiratory failure due to:
Unstable angina or ongoing acute myocardial infarction;
Acute respiratory acidosis with pH < 7.35 and PaCO2 > 45 mmHg;
Hemodynamic instability and/or use of vasopressors/inotropes;
Altered mental status (Kelly >3), see Figure 1;(18)
Contraindications to NIV (high risk of aspiration pneumonia, impaired airways protection, head-facial trauma and/or burns, uncooperative patient, cranial/thoracic/abdominal open wounds);
Indications to urgent intubation performed according to the clinician in charge;
Body Mass Index > 35 kg/m2;
Pregnancy;
Patient's refusal to participate.
Primary purpose
Allocation
Interventional model
Masking
234 participants in 2 patient groups
Loading...
Central trial contact
Francesco Franceschi, MD; Gianluca Tullo, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal